Armstrong Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Armstrong Advisory Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.7K	Buy	369 +1	+0.3%	+$95	﹤0.01%	496
2026 Q2	$31.7K	Hold	368	–	–	﹤0.01%	514
2026 Q1	$33.3K	Sell	368 -40	-10%	-$3.67K	﹤0.01%	479
2025 Q4	$36.7K	Buy	408 +1	+0.2%	+$95	﹤0.01%	447
2025 Q3	$40.1K	Hold	407	–	–	﹤0.01%	433
2025 Q2	$37.1K	Hold	407	–	–	﹤0.01%	432
2025 Q1	$43K	Hold	407	–	–	﹤0.01%	388
2024 Q4	$43K	Buy	407 +1	+0.2%	+$107	﹤0.01%	388
2024 Q3	$43.9K	Sell	406 -40	-9%	-$4.36K	﹤0.01%	386
2024 Q2	$48.4K	Hold	446	–	–	﹤0.01%	362
2024 Q1	$54.3K	Hold	446	–	–	0.01%	334
2023 Q4	$54.3K	Hold	446	–	–	0.01%	334
2023 Q3	$50K	Buy	446 +1	+0.2%	+$127	0.01%	334
2023 Q2	$64.8K	Sell	445 -8	-2%	-$1.09K	0.01%	306
2023 Q1	$58.6K	Hold	453	–	–	0.01%	302
2022 Q4	$57.8K	Buy	+453	New	+$52.6K	0.01%	301

Other funds holding ZBH

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Wilsey Asset Management San Diego, California $681M AUM 1.1% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Northside Capital Management Hood River, Oregon $1.25B AUM 16.02% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Armstrong Advisory Group's ZBH Position: Q3 2026 in Review

Armstrong Advisory Group increased its Zimmer Biomet (ZBH) stake by 0.27% in Q3 2026, buying an estimated $95 and bringing the position to 369 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

Armstrong Advisory Group first reported a position in ZBH in Q4 2022 and has held it in 16 quarters since. The position peaked at $64.8K in Q2 2023. 176 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Armstrong Advisory Group held 369 shares of Zimmer Biomet worth $32.7K as of Q3 2026.
Armstrong Advisory Group bought 1 Zimmer Biomet share in Q3 2026, an estimated $95.
Zimmer Biomet made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #496 holding.
Armstrong Advisory Group first reported a position in Zimmer Biomet in Q4 2022 and has held it in 16 quarters since.
Armstrong Advisory Group's Zimmer Biomet position peaked at $64.8K in Q2 2023.
176 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.